In late 2025, Russian medical researchers officially transitioned from pre-clinical success to human clinical trials for a revolutionary, domestically developed mRNA cancer vaccine. This therapeutic vaccine, developed by the Gamaleya National Research Center (the creators of Sputnik V), represents a landmark shift toward personalized precision medicine designed to treat patients already diagnosed with malignancy. The vaccine leverages advanced messenger RNA (mRNA) technology to instruct the pati